Clearpoint Neuro Inc
NASDAQ:CLPT
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Bristol-Myers Squibb Co
NYSE:BMY
|
Pharmaceuticals
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Altria Group Inc
NYSE:MO
|
Tobacco
|
|
US |
LL Flooring Holdings Inc
NYSE:LL
|
Retail
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Cloudflare Inc
NYSE:NET
|
Technology
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
5.2502
13.46
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
Bristol-Myers Squibb Co
NYSE:BMY
|
US | |
Abbvie Inc
NYSE:ABBV
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Altria Group Inc
NYSE:MO
|
US | |
LL Flooring Holdings Inc
NYSE:LL
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Cloudflare Inc
NYSE:NET
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
Coca-Cola Co
NYSE:KO
|
US |
This alert will be permanently deleted.
Clearpoint Neuro Inc
Accrued Liabilities
Clearpoint Neuro Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Clearpoint Neuro Inc
NASDAQ:CLPT
|
Accrued Liabilities
$5.3m
|
CAGR 3-Years
17%
|
CAGR 5-Years
29%
|
CAGR 10-Years
15%
|
||
Becton Dickinson and Co
NYSE:BDX
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Boston Scientific Corp
NYSE:BSX
|
Accrued Liabilities
$2.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
||
Stryker Corp
NYSE:SYK
|
Accrued Liabilities
$3.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
3%
|
||
Abbott Laboratories
NYSE:ABT
|
Accrued Liabilities
$6.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
||
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accrued Liabilities
$867.5m
|
CAGR 3-Years
21%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
Clearpoint Neuro Inc
Glance View
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.
See Also
What is Clearpoint Neuro Inc's Accrued Liabilities?
Accrued Liabilities
5.3m
USD
Based on the financial report for Sep 30, 2024, Clearpoint Neuro Inc's Accrued Liabilities amounts to 5.3m USD.
What is Clearpoint Neuro Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
15%
Over the last year, the Accrued Liabilities growth was 47%. The average annual Accrued Liabilities growth rates for Clearpoint Neuro Inc have been 17% over the past three years , 29% over the past five years , and 15% over the past ten years .